Copyright
©The Author(s) 2021.
World J Diabetes. Oct 15, 2021; 12(10): 1622-1654
Published online Oct 15, 2021. doi: 10.4239/wjd.v12.i10.1622
Published online Oct 15, 2021. doi: 10.4239/wjd.v12.i10.1622
Effect/ function/ action/ characteristic | E1 | AE1 | E2 | AE2 |
Bind the ERs at the hormone binding site | ↑↑2 | X | ↑↑2 | ~ |
Bind the AF1 or AF2 sites of the ERs | X2 | ↑ | X2 | ~ |
Bind to mitochondria (and some membranes) | ~ | ~ | ↑2 | ↑2 |
Elicit a direct classic estrogenic response | ↑2 | X | ↑↑2 | ↑↑2 |
Induces hypoglycemic effects | ~i | ↑↑2 | ↑2 | ~ |
Is carried by lipoproteins | ↑2 | ↑↑2 | X | ↑2 |
Show anti-oxidative effects | ~ | ~ | ↑2 | ↑↑2 |
Activate the 3C→2C conversion (pyruvate dehydrogenase) | ~ | ↑2 | ↑↑2 | ~ |
Increase mitochondrial oxidative activity | ~ | ~ | ↑ | ~ |
Increase whole body thermogenesis | ~ | ↑2 | ↑2 | ~ |
Show lipolytic effects | X | ↑ | ↔ | ~ |
Show lipogenic effects | ↑ | ↓2 | ↓2 | ~ |
Decrease WAT fat mass/ limits fat deposition | ↓ | ↑↑2 | ↑2 | ~ |
Allow the activation of the alternative N disposal pathway | ~ | ~ | ↑ | ~ |
Decrease body protein mass | ↔ | X2 | X2 | ~ |
- Citation: Alemany M. Estrogens and the regulation of glucose metabolism. World J Diabetes 2021; 12(10): 1622-1654
- URL: https://www.wjgnet.com/1948-9358/full/v12/i10/1622.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i10.1622